CHARITY COMMISSION Lung Cancer Nursing UK ANNUAL REPORT AND ACCOUNTS FINANCIAL YEAR ENDING JANUARY 2024 Charitable Incorporated Organisation number: 1160011 LUNG CANCER NURSING UK I FIFTEEN Rosehill. Montgomery Way, Rosehill Estate CARLISLE. CAI 2RW
TRUSTEES, REPORT Forthe yearended 31j•nry2o24 About LCNUK Lung Cancer Nursing UK was established in 1998 to support the advancement of health by providlng nurses who specialise in the treatment of patients with lung cancer or mesothelioma with support, education and the opportunity to communicate and network with peers,. and to provide a national voice on clinical and strategic issues for specialist lung cancer nurses. The organisation became a charitable incorporated or8anisation (CIO) in 2015. Membership is open to any specialist nurse who spends more than 50% of their working week or clinical activities in caring for patients with lung cancer and or mesothelioma. Associate membership is open to those who do not meet this criteria. The experience and clinical background of the members working environments are very diverse, including. palliative care, oncology {cancer centres or units) respiratory medicine, community and others, this affords the organisation a wealth of knowledge which members can access. The activities of the CIO fall into four distinct categories, these are as follows: Clinical Improving the care lung cancer patients receive. Disseminating best practice and sharing information and knowledge Developmental Keeping members up-to-date with the latest lung cancer news through our e-bulletins Highlighting new developments in the UK. Encouraging re8ional participation within LCNUK Education Providing a forum to disseminate new developments, skills, treatments and practice through educational programmes, annual conference, resources and publications Sharing clinlcal updates and best practice with members Supporting and fosterin8 audit and research in lung cancer and within the role of the LCNS Professional Providing support and networking, infrastructure and opportunities. Campai8ning for and supporting the role of the lun8 cancer nurse specialist Providin8 a voice on clinlcal and strategic issues. Hi8hlightin8 the specialist role of nurses In caring for people with lung cancer and mesothelioma Representing lung cancer nurse specialists on national and international bodies and organisations WNG CANCER NURSING UI( IA charltable 5ncorporated ory•nlsathn ICIO-Charlty Nurnr 11600111 Page I
TRUSTEES, REPORT Fortheyearended 31 J•nuary2024 2024 Business Priorities The Trustees present their annual report together with the financial statements of the charity for the year I February 2023 to 31 January 2024. The Trustees confirm that the Annual Report and Financial Statements of the charity comply with the current statutory requirement5, the requirements of the charity's governing document and the provisions of the Statement of Recommended Practice ISORPI applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland IFRS1021 (effective l January 2019). The Trustees have complied with the duty in part I section 4 of the Charities Act 2011 to have due regard to public benefit guidance published by the Charity Commission. A detailed report of the activities undertaken and achievements by the Charity to further its charitable purposes for the public benefit is given below. In 2024 LCNUK had the following busine55 priorities: Professional To act as advocates for patlents with lung cancer on national professional bodies such as NICE/BTOG. To represent the lung cancer nurse specialist on professional bodies and committees and provide a voice on strategic issues at a regional and national level. To promote the lun8 cancer nurse specialist role and its benefits on an international platform. To share best practice in lun8 cancer and mesothelioma care. Developmental To ensure production and circulation of a monthly e-bulletin to share best practice and highlight lung cancer and relevant nursing news and events. To maintain the LCNUK website creatin& sharing and signposting to relevant news and events, Education and Clinical Annual Conference May 2024-To provide ongoing professional education to lung cancer nurse specialists through its annual conference. To provide regular educational programmes of activity. Research To support ongoing research programmes with academic institutions and provide small research grants to support lung cancer nurse specialists taking their first steps in research and those seeking advanced care practitioner status. 2023 Impact report In 2023, workforce pressures continued to impact significantly on Lung Cancer Nurse Specialists. The legacy of COVID-19 coupled with the continued pressure under which the NHS is currently operating has resulted in a workforce that is struggling under the strain. The ageing workforce is also more apparent with many lung cancer nurse specialists opting to retire, reduce working hours or take on less stressful roles. WNG CANCER NURSING UK IA thafft•ble In¢orporatsd or8anksatlon ICIO- Charlty Number IIWIII Page 2
TRUSTEE5' REPORT ForthtVEarended 31J4nuary 2024 The struggling workforce impacts on what LCNUK. as a professional organisation. can do to support the workforce. Increasingly, we have had to resort to the development of short form digital media to SUPPOrt education and professional development as fewer nurses are able to take time away from the coal face for meetings and courses. Much of the workforce continues to be challenged by the ongoing cost of living crisis which only serves to exacerbate the demoralised workforce. During 2023 membership declined slightly. The charity is looking to reverse this by introducing new member features and benefits including podcasts and online learning modules. New Renewed ired 95 178 114 113 179 86 282* 50. 156. 82 180 'Any member who pald for a membershlp In 2020, has had thelr membership end date extended to 2022 As part of a review of activity we have worked to develop new programmes to be introduced in 2024 that will increase the benef its of being a member. These include online learning modules, leadership development grants and podcasts. We have also developed a new associate membership scheme for those workin8 in navigators/supporter' roles. This was launched at the end of 2023 and a programme of activity for navlgator members Is in development. Professional Inf luencing and contribution to national policv LCNUK works alongside numerous organisations across the UK to inform lung cancer policy, promote best practice and act as the patients advocate for people with lung cancer. In 2023, we contributed to collaborate with national bodies including NICE, BTOG, UKLCC, Roy Castle Lung Cancer Foundation and other lung cancer related or8anisations to support the development of national policy and guidelines. The organisation has continued to support Lung Cancer Europe Activitles which have had number of initiatives taking place and members have submitted abstracts to the IASLC World Conference on Lung Cancer. Navl8atorlsupporter role5 as descrlbed in the National Optimal Lun8 Cancer Pathway support healthcare professlonals by takln8 on administrative ar¢d coordinator roles to support Lung Cancer Nurse Speclallsts and delSver a more patient friendly and patlent centred experience The committee of LCNUK initiated discussions on a programme of work to assess workload and the increase in levels of patient dependenry during this period with a view to a new programme of work to explore this in late 2023/early 2024. WNG CANCER NURSING VK IA th•rtt•bl• IncOOrated oryan55atknn ICIO-Charlty Number 11600111 Page 3
TRUSTEES, REPORT For the year ended 31 january2024 Representation Brltlsh Thoracic Oncology Group Global Lung Cancer Coalition International Thoracic Oncology Nurses Forum Lung Cancer Europe Mesothelioma UK National Lung Cancer Audit National Institute for Health and Care Excellence Roy Castle Lun8 Cancer Coalitlon Scottish Mediclnes Con50rtium Scottish Lun8 Cancer Nurses Forum UK Lung Cancer Coalition Welsh Lung Cancer Nurses Forum Developmental Communicating with our members LCNUK has continued to deliver short form easily-to-access succinct communications with members providin8 bite-size news and information that can be absorbed in the short window of time available to our members. To do this we continue to use social medla to push out key messages, regularly update the content on our website with direct links from the home page to key important lung cancer and nursing news. We also prepare and deliver a monthly members newsletter featuring bite-size news and signposting members to educational and professional development information as well as updates on key lung cancer news and links to other charity and not-for-profit news. Education and clinical In 2023 we hosted an annual conference at The Eastside Rooms in Birmingham. The conference attracted 275 attendees of which 145 were members of LCNUK. 96% of those who completed the evaluation reported that the conference was relevant to their educational needs with similar numbers reporting that the Information was well presented by knowled8eable and appropriate speakers. When asked to describe their conference experience delegates stated "informative", "educational interesting" "friendl,, "networkin and "inspirational" as the most commonly used words. Despite this good feedback, the committee have noted that feedback is slightly lower than in 2022 and a review of content has been undertaken in 2023 with plans to increase clinical and symptom control sessions at the 2024 conference. The conference was able to raise much needed funds in 2023,. this was particularly important since we were not able to secure core sponsorship in 2023. LU146 CANCER NURSING UK (A charlt•bl• In¢orpor•ted oryan15atSon ICIO-Ch•rlty Numb•r 116(rfJiil Page 4
ThLISTEES' REPORT For the ar ended 31January 2024 The organisation hosted four webinars in 2023 which members could attend live or watch on-demand at their leisure. These included: Challenges of managing lung cancer through virtual clinics: discussion and top tips Virtual 10/0212023 clinics webinar. Supporting parents to prepare their children when a parent's lung cancer cannot be cured Understanding lung cancer staging from the radiologist point of view Andrea Mclver and Martin Ledson Andrea Cleary, Deepa Doshi, Ruth Strauss Foundation 2710912023 1410612023 Allanah Barker ,How to prepare a scientific poster 18110/2023 Lara Roskelly The organisation also held an annual project workshop which explored inequalities in people affected by lung cancer. The results of this work were submitted to the British Thoracic Oncology Group for presentation and will be presented at the LCNUK conference. Research LCNUK has a small workgroup of artive members interested in research (known as RIG- Research Interest Group) initially led by Dr Cathy Henshall, Research Interest Group Lead for LCNUK in 2023. The group have also been contributing to research projects in never smokers and access to clinical trlals, The group relaunched the small grants opportunity in 2023 and successfully awarded a grant of £4,530 to LCNUK member, John McPhelim, to undertake the project, Monltorlng and assesslng Immunotherapy related toxlcity uslnq humon centrlc causal artlficlal Intelllqence{AlJ learnlnq appmach. 13 abstracts were submitted to the LCNUK annual conference Ivs 18 in 20221. We have also relaunched our annual award programme in 2023 and received three applications. Another sub-group of members, the thoracic surgical group, are also working on a project, .15 surqlcal follow-up eqUltableAorullpatlent. The results of work will be submitted as an abstract for presentation at a national conference. Plans For Future Periods In 2024, LCNUK will be finalising its plans and implementing a programme of work to develop a patient dependency tool to assess the levels of dependency on LCNS across the lung cancer pathway. We will also be introducing a new bursary scheme of £20,000 to support lun8 cancer nurse specialists to undertake further training in leadership skills through approved NHS training providers and/or The Kings Fund. We will be seeking to influence the national agenda to ensure that patients have appropriate access to lung cancer nurse specialists so that they can act as the patients, ambassador and representative. We will continue to disseminate and share the LCNUK professional framework which sets out the key skills and training required for the role of a lung cancer nurse specialist and introducing an extension to the LUNG CANCER NURSING UK {A charlt*bh In¢orporat•d organlsatlon lao- Chaylty Number 11600111 Page 5
TRUSTEES. REPORT Forthe aren0*d 31Jènuary2024 framework to outline the key skills and knowledge. for lung cancer navigators/support workers. Our framework has also been very well received in Poland and a member of the committee will be providing training on the framework through an agreement with the Polish Government. We will explore how best to support, foster and harness research and audit by lunB cancer nurse specialists and to share best practice and service development for the benefit of people with lung cancer through our new research lead, Suriya Kirkpatrick. We will promote best practice through the sharing of clinical knowledge and skills at our annual flagship two-day conference in June 2024. We will continue to work with partner organisation5 to support the restoration and improvement of lung cancer services post pandemic. We will complete the thoracic surgical project exploring varlatlon in follow-up and submit as an abstract to a national conference. We will continue to support member education with ongoing webinars and other digital learning which are now an established feature and benefit of membership. We will also be introducing a new programme of online learnin8 modules to support those who are new to the specialism and a series of podcasts to further support learning. We will continue to promote member communications, the sharin8 and dissemination of relevant lung cancer news and information. We will continue to act as patient representatives and advocates at a national policy level. Structure, Governance & Management Constitution The charity is a registered charitable incorporated organisation, charity number 1160011. Formal membership is open to any lung cancer nurse specialist who spends more than 50% of their working week or clinical activities in caring for patients with lung cancer or mesothelioma. In addition, membership is open to nurse specialists in a lung cancer/mesothelioma academic or lun8 cancer/mesothelioma research role. Such membership is subject to approval by the LCNUK Committee. Associate membership is open to those who do not meet the criteria for formal membership. Method of appointment and election of trustees The management of the charity is the responsibility of the trustees who are elected and co-opted under the terms of the constitution. During this period the LCNUK was managed by seven trustees, led by Lorraine Creech who completed her term of office on 4 January 2024. Diana Borthwick replaced Lorriane Creech on th 5 January 2024 after being elected the new chair by the board of trustees. The trustees. or any member of LCNUK can recommend a trustee for appolntment. One third of the trustees retire each year and may be re- appointed. Applicants are asked to provide a CV and covering Statement. A shortlist is drawn up and interviewed by a panel appointed by the Board of Trustees. Three new trustees were co-opted by the board of trustees in August 2023, Nicola Handley, Dominic Smith, Catherine Haywood; these individuals will be put forward for election at the next annual general meeting of the charity. The three new trustees bring legal and marketing expertise. Professor David Baldwirb was also elected by the membership to the board of LUNG CANCER NURSING UK IA charltable In¢orpor•t•d oryanltI lao- Charfty Number 11600111 Page 6
TRUSTEES. REPORT For the year ended 31 January2024 trustees in May 2023. Professor Baldwin is a highly respected leader in the diagnosis and management of lung cancer. Policies adopted for the induction and training of trustees A trustee recruitment and induction pack is available to support new trustees in learning about the organisation, its role, governance and responsibilities of trustees. LCNUK is also a member of the National Council for Voluntary Organisations to take advantage of governance trainin8 Opportunities. Organisation structure and decision making The Trustees are assisted by the LCNUK Committee. The chair of the LCNUK committee attends trustee meetings to ensure continuity and good communications. During 2023 the committee was comprised of 12 elected members of LCNUK and three co-opted members, Suriya Kirkpatrick, Alison Edwards, Matthew Kelly. The LCNUK committee formulates recommendations on the aims, strategies and activities of the charity for approval by the trustees. An agency, Red Hot Irons Llmlted (RHII, Is contracted to run the day-to-day business administration and operations of the organisation. Pay Policy for key management There are no paid staff, all work undertaken by the committee and trustees is done so voluntarily. The support agency is contracted to run the operational day-to-day activities and business administration. Application and adherence to the Charity Governance Code LCNUK recognise good governance is essential to our effectlveness, reputation and credibility. The Board of Trustees regularly review activities. policies and processes to ensure the charity is delivering against its mission and charitable objectives. We have robust measures in place to ensure effective and clear overview of financial contro15. The board undertakes a regular review levery two years) of its effectiveness, assessing competencies, skills 8aps and training needs throush a process of external audit and facilitated discussion. In 2023, LCNUK adopted four new policies; on engagin8 external speakers, anti-harassment and bullyin8, serous incident reporting and social media and reviewed and updated two existing policies. The Investment and rlsk management policies were also reviewed as part of the routine governance of the organisation. The trustees also reviewed the role descriptions for the chair and vice chair of the board of trustees. We operate a robust conflicts of interest policy. and all Trustees and Committee members complete declarations of interest each year. Conflict of interests form a standing item on all committee/board agendas. The Board aims to continuously improve its governance processes and is currently working through the new Cha rit Governa nce Code to ensure its governance structures adhere to the principles of the code and recommended practice. Risk management The Trustees analyse and undertake a review of the risks the Charity is exposed to as part of an annual business planning process and in accordance with Charity Commi55ion 8uidance {CC26), scoring the risks according to likellhood and impatt. The systems and actions established to mitigate those risks are also reviewed by Trustees at each Board meeting and updated and adjusted accordinglyi With the net risk in each area agreed. High risks closely monitored by the Trustees are: LUNG CANCÉR NURSINfj UK IA charllable 5n<orporated ory•nlMtfjon ICIO-Charlty Number 11600111 Page 7
TRUSTEES, REPORT fortheyearended 31January 2024 High level of dependenry on too few income streams puts LCNUK at risk of sudden and/or long-term loss of funding- efforts continue to diversify income streams to include more Trusts and Foundation as well as funding from non-pharmaceutical companies. Potential for a sudden drop in income and the need to dip into accumulated reserves The risk that LCNUK could be perceived as being unduly influenced by sponsorslpharmaceutical industry. LCNUK has adopted a stringent endorsement policy and ensures where possible that there is a balance of sponsors from across the industry spectrum with no one sponsor having significant influence or control. Sponsors are not permitted to have any form of editorial control or influence over the content and development of new LCNUK branded materials Volunteers The Society is heavily reliant on the time, expertise and energy of its committee and other members. Much of the work of the charity is conducted virtually via email and teleconference and is undertaken on a voluntary basls. WNfj CANCER NURSING UK IA th•rtt4bl• Incorporated organlsatlon l(K>- tharFty Number 11600111 Page 8
TRUSTEES, REPORT Fprthe yearended 31 January2024 Trustees, executive committee & senior management Trustees LCNUK Committee Lorraine Creech George Bate Diana Borthwick Ichalr- appointed January 5 20241 Nicola Handley (co-opted 8 August 20231 Catherine Haywood (co-opted 29 August 20231 Alison Leary 150bel Lovett Domlnlc Smith Ico-opted 8 August 20231 Rory Underwood {removed 29 February 20241 John White David Baldwin {co-opted 12 May 20231 Victoria Anderson Peter Barton Karen Clayton ICHAIRI Tracey Cole (removed 30 Au8USt 20231 Pamela Dalrymple Marie Eaton Sarah Ivey Lavinia Magee Julia McAdam Jennifer Ross Paula Shepherd Chailotte smith (elected 2 October 20231 Bing Smlth (elected 2 October 20231 Registered office clo Dodd & Co FIFTEEN Rosehill Montgomery Way Rosehill Estate CARLISLE CAI 2RW Co•OPted LCNUK Commlttee members Suriya Kirkpatrick (Research Interest Group Leadl Matthew Kelly INI representative) Alison Edwards Iwelsh representative) Accountants Dodd & Co Chartered Accountants FIFTEEN Rosehill Montgomery Way Rosehill Estate Carlisle CAI 2RW Charity Registered Number 116(M)ii Bankers Unity Trust bank plc Nine Brlndley Place Birmingham 812HB Nationwide Building Societv Nationwide House Plpers Way Swindon SN38 INW LUNG CANCER NURSING UK (A ¢h•rlt•bl• Inmrporated or8an55atlon (cio- Chartty Number 11600111 Page 9
TRU5TEES' REPORT Forthe year ended 31January 2024 Financial Review Principal Funding The principal funding sources for the Charity in 2023 as in previous years were: Voluntary income from the pharmaceutical industry (fees from the LCNUK Corporate Sponsorship) Income from sponsorship of charitable activities by pharmaceutical companies andlor solicitors Membership fees The total funding secured in 2023 £164,222 was 16.7% lower than in 2022 {£197,199). Regretfully, LCNUK was unable to secure corporate sponsorship or sponsorshlp for webinars in the accounting period. Interest rates did help to provide a small additional income. Membershlp fees were slmllar to 2022 with membership static at around 300 members. Principal Expenditure Total expenditure in 202312024 was £155,939 which was compared to £146,945 in 2022/2023. Reflectlng the general increase in the cost of living and interest rates at the time. The largest item in support costs was secretariat, membership and administration costs, which includes fees paid to Red Hot Irons. Red Hot Irons Is contracted to run the day-to-day operatlons of the charity, including malntenance and upkeep of our webslte, membershlp management and communlcatlons, commlttee management, events, IT, webinars, analytics and database. Reserves Policy LCNUK has no regular guaranteed sources of income and the lon8-term fundlng of the charity is uncertain. The charity however does have fixed operating Costs in terms of the activities required to maintaln its presence and further its charitable objectives. The charity's work is planned one year in advance wlth financial commitments made up to two years in advance on some programmes such as the annual conference. The Trustees have therefore decided that to see programmes through to completion in the event of a serious reduction in funding, an optimal reserve equivalent to twelve months fixed operating costs plus the annual cost of the conference Should be held, This level of reserve also supports the charity in working to a long-term strategy without the need to make short term adjustments forced on it by temporary deficits in funding. Moreover, it allows the charlty to take advantage of opportunities that may present and require a relatively small or moderate investment upfront. Minimum and maximum levels of reserve5 have been agreed as 6 months costs and 18 months costs respectively. The Trustees will be guided only to take drastic action if they see the charity f311ing below its minimum level of reserves and to only make significant long- term investments from reserves if the Charity is above its ideal level of reserves. The optimum level of resenie based on the 2024 bud8et amounts to £200k with a minimum of £IOOk. The level of unrestricted reserves held by the society at the end of the accounting period (Jan 2024} was £328,575, which meets the optimum level of reserves. The Board undertakes an annual review of the reserves policy to ensure it reflects current activities of the charity and amounts held in reserve are sufficient meet the financial and charitable obligations should funding significantly diminish for any reason. LUNG CANCER NURSING UK {A charltable Incorporated oryanlsatknn ICIO- Charlty Number 11600111 Page 10
rRv5TEES' REPORT For the ¥ear ended 31 January 2024 Going concern After making appropriate enquiries, the Trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements. Further details regarding the adoption of the going concern basis can be found in the accounting policies. Financial Review Conclusion The Society ended the year with a surplus of £8,283 for the accounting period. The charity continues to hold healthy reserves. However, sponsorship and funding remain a significant challenge and operating costs continue to rise particularly around venue hire charges and insurance costs. The Trustees recognise that the funding situation remains challenging and will continue to be innovative in our approach to fundraising, cost savings and ensuring value for money. We will also look to achieve additional funding from grant making bodies. Statement of Trustees, responsibilities The Trustees are responsible for preparing the Trustees, report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kin8dom Generally Accepted Accounting Practice). Charlty law requires the Trustees to prepare financial statements for each financial year. Under charity law the Trustees must not approve the financial statements unless they are satisfied that they give 3 true and fair view of the state of affairs of the Charity and of its incomin8 resources and application of resources, including its income and expenditure, for that period. In preparin8 these financial statements, the Trustees are required to: select suitable accounting policies and then apply them consistently; observe the methods and principles of the Charities SORP IFRS 1021; make judgments and accountin8 estimate5 that are reasonable and prudent,. state whether applicable UK Accounting Standards IFRS 1021 have been followed, subject to anv material departures disclosed and explained in the financial statements; prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in business. The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the charity's transactions and disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial Statements comply with the Charities Act 2011. They are also responsible for safeguarding the assets of the charity and hence for takin8 reasonable steps for the prevention and detection of fraud and other irregularities. Disclosure of information to auditors Each of the persons who are Trustees at the time when this Trustees, report is approved has confirmed that: so far as that Trustee is aware, there is no relevant information of which the charity's accountant and independent examiner are unaware, and WNG CANCER NURSING UK IA ¢h•rltabl• Intorporated OryanItkIn ICIO-Chawlty Number 11600111 Page 11
TRUSTEE5' REPORT ForthEyearendEd 31 Januiry 2024 that Trustee has taken all the steps that ought to have been taken as a Trustee in order to be aware of any relevant information and to establish that the charity's accountants are aware of that information. Approved by order of the members of the board of Trustees and signed on their behalf by: Diana 8orthwick Chair of the Board of Trustees LUNG CAIKER NURSING UK IA¢h•rlt•bS• Inc•fpwated ¢Kganlsatlon ICIO-Charlty Number 116(M)Iil Page 12
Independent Examlnerfs Roport to the Trugtees of Lung Cancer Nursing UK I report on the accounts of th8 charity for the year ended 31 January 2024. which are set out on pages 14 to 22. Your attention is to drawn to the fact that the Charity has preparéd the finanrial statements in accordance v Accounting and Reports'ng by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 1021 in preference to the Accounting and Reporting by Charits'es.. Slalement of Recommendèd Practice issued on 1 April 2005 which is referred to in the exiant r•9ulations but ha$ 8in¢o been withdrawn. We understand that this has been done in order for the accounts to provide a true and fair view in accordancè wrth the Generally Acceptad Accounting Practice effe¢ts've for reporting periods beginning on or after 1 January 2019. Rèspoctlvo rosponslbllltlos of truitee• and oxamlner The Charity's trustees are responsible for the preparalion ol the accounts. The trust88s consKler that an audrt is not required for this year under sethon 144{2} of the Charities Act 2011 (Ihe 2011 Actl and that an independent examination Is neeaed. It is my responsibilty to. examiné the accounts under séction 145 of the 2011 Act., follow the procedures laid down in the General Directions given by the Charity Commission under s8th.on 145151 (bl of the 2011 Act, and state whèther particular matters have come to my attention. B•818 ol Indop•nd•nt ?x•mlnof• roport My examination was camèd out in accordance with the General Directions given by the Charity Commission. An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented wth those records. 11 also includes consideration of any unusual items or disclosures in the a¢unts, and seeking explanations from you 88 Iruslees concerning any such matt&TS. The procedures undertaken do not provide all the evidence that would be required in an audit and consequenlly no opinion is givèn as to whether th8 accounts presenl a Irue and fair vièv/ and the report is limited lo those matters set oul in the statement below. Indop•ndont examlnar'i 8tstsrn•nl In connection Vth my examination, no matter has come to my attenlion.. {1} which gives m? rea8ongble ¢ause to believe that in any material respect the requirement8'. to keep accounting records in accordance wth section 130 of the Charitie5 Act 2011., and lo prepare 8c¢ounts which accord wth Ihe accounting records. comply with the accounbng requirements of the 2011 Act have not beèn met.. or {2) lo which, in my opinion, attention should be drawn in order to enable a proper underslanding of the accounts to be reached. FIFTEEN Rosehill Montgomery Way Rosehill Estate CARLISLE CA12RW ne inson FCA dd & Co Limited hartered Accountants 15 April 2024 Pege 13
Lung CanGeT Nursing UK known as LCNUK Statement of Flnanclal Activfties for the Yoar Ended 31 January 2024 Unrestrlctod Total Funds Total Fund8 Fund• 2024 2023 Not0 Incomo and ondowmonts from: Donations and legarjes Investment income Charitable activities Tolal income 123,100 1,086 40,036 164,222 123,100 1,086 40,036 164,222 159.987 192 37.020 197.199 Expondlturg on: Charitsble 8Ctivitl8S Totsl expenditure 155,939 155,939 155,939 155,939 146.945 146.945 Nel movements in funds 8,283 8.283 50.254 R•conclllatlon of funds Total funds brought forward Total lunds carned lorwarcl 320,292 328,575 320,292 328,575 270.038 320.292 The notes on pages 16 to 22 form an integral part of Ihese financial statements. Page 14
Lung Cancer Nursing UK trading as LCNUK Balance Sheet as at 31 January 2024 2024 2023 Nots Currnnt a88ets Debtors Cash at bank and in hand 10 48,232 338,078 80,469 252,241 386,310 332.710 Credllorn: Amounts falllng due wlthln on• yoar 157,7351 112.4181 Not ¢urr•nt a8•0ts 328,575 320,292 N•t 488•ts 328,575 320,292 Tho fund8 of th• charlty: Unro•trlct•d fund• Unrestricted incomè fund8 328,575 320.292 Total charlty fund8 The financial Statements have been prepared in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 1021. 328,575 320,292 Approved by the Board on 15 Apnl 2024 and signed on its bèhalf by.. D Borthwck Trustee The notes on pages 16 to 22 fomi an integral part of these financial stalements. Page 15
Lung Cancer Nursing UK known as LCNUK Notes to the Flnanclal Ststements for the Year Ended 31 January 2024 AcGountlng pollcl?• Statsmont of eompllance The accounts (financial stalementsl have been ppared under the historical cost convention with items recognised at cosl or transaction value unless otherwise slated in the relevant notels) to these accounts. The financial slatem6nts have been prepared in accordance with the second edition of thè Charities Statement of Recommended Practice issued in October 2019, the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland {FRS 1021 and the Chanties 2011. The accounts (financial statement8) have been preparéd to give a '1 and fair, view and h&v8 depart8d from the Charrties IAccounts and Reports) Regulations 2008 only to the extent required to provide a 'true and fair view.. This departure has involved following Accountin9 and Reporting by Charitie5 preparin9 their accounts in a¢¢ordance wilh the Financial Reporting Standard applicable in the UK and Republic of Ireland IFRS 1021 rather than the Accounting and Reporting by Charities,Statement of Recommended Practs'ce effective from 1 April 2005 which has since b88n withdrawn. B•$ls of prnparallon The charity meels the definition of a public bonefil entity under FRS 102. Assets and liabilities are initially racogniwl at historical cost or transaction value Un$$ othemse stsl8d in the r818vant accounting policy notes. Golng con¢•m These financial stat&menls hav8 been prepared on 8 90ing concern basis.The twslees assess whether the use of going concern is appropriate i.e. vthether the are any matèrial uncertainties related lo events or conditions that may cast significant doubl on the ability of the Charity lo continu8 as 8 going concèm. The trustees make this assessment in respect of a p8nod of one year from Ihe date of approval of the financial statem&nt$. Fund a¢¢ountlng pollcy Unrestricted income funds ar8 general funds that are available lor use at the trusl6es' discretion in fiJrtherance of the objectives of the chanty. Further details of each fund are disclosed in note 13. Income and 0nd0ents Donations and legacies including gifts are recognised where there is entrtlement. probability of rèceipt and the amount can be measured with Sufficient reliability. Income from Government and other grants. whèthèr 'capit81' grants or 'revenue' grants, is recognised vthen the charity has entitlemènt to the fvnds. any rforManCe condibons attached lo the grants have been met, it is probable that the income wll be received and the amount can be measured reliably and is not deferred. Gifts in kind are recognised in different ways dependent on how they are used by the ¢harrty'. lil Those donated for resale produce income when they are sold. They are valued at the amount actually realised. lill Those donaled for onward transmission lo beneficiaries are included in the statemenl of finan¢ial activities as incoming resources and resources expended when they ar8 distributed. They are valued al the amount the charity would have had to pay to acquire them. liiil Those donated for use by the chanty itself are induded when Tec8ivable. They are valued at the amount Ihe charity would have had lo pay to acquire thern. Page 16
Lung Cancer Nurslng UK known as LCNUK Notes to the Flnanclal Statements for the Year Ended 31 January 2024 . conbnued Where faeililies are providgd to the charity as a donation that would nomally be purchased from our suppliers, this contribution is included in the financial statements at an estimate based on the value of the contribution to the chanty where this can be quantified. The value of services provided by volunteers is nol incorporated into these financial ststements. Further details of the contribution made by volunleers can be found in the Trustees, Annual Report. Investment intome is recognised on a receivable basis. Income fri>m charitable activities includes income recognisèd as eamed (as the related goods or services are provad) under contract. Membership incom8 is recognised on receipt. Exp•ndltur• Liabilities are recognised as soon as there is a18gal or constructive obligation commrtting the charity to the expendrture. All expenditure is accounled for on an accruals basis and has been classified under hèadings that aggrogate all costs related to the tegOry. Expendilure on raisin9 funds arè the Gosts of tradin9 for fundrai51ng purposes. Chanlable expendilure comprises those costs incurred by the charity in the delivery of its activiti8s and services for its beneficianes. It includes both costs that can be allOted directly to Such actI'e$ and those costs of an indirect nature necessary lo support them. Grants payablè are payments made to third parties in the fvrtherance of the charitable objectives. Where the charity gives a grant with conditions for its payment being a specific le1 of Sèrvice or oulpul to be provided. such grants are only recognisèd in the SOFA oncé thè recipient of the grant has providéd the specific service or outPLrt. Grants payable wilhoul performance conditions are only recognised in the accounts when a commitment has been made and theré are no conditions to be met relating lo the grant which ramain in the conlrol of the charity. Provisions for grants are made when the intention to make a 9rant has been communicated to the recipiént but therè is uncertainty about either the timing of the grant or the amount of grant payable. Support co•1• Support costs include cèntral functions and have been allocated lo acbvily cost Galegories on a basis consistent with the use of resources, for example, allocating property costs by floor amas. or per caprta. staff costs by the time spent and other costs by thèir usage, lff•coverable VAT Irrecoverable VAT is charged against the category of resources expended for vthich it was incurred. Cash and C•8h Equlval•nts Cash and cash oquivalenla comprise cash on hand and Gall deposits, and other short-temi highly liquid investrnents that arè readily convertible to a known amount of cash and are subject to an insignificant risk of change in value. Page 17
Lung CanGeT Nursing UK known as LCNUK Notes to the Flnanclal Statements for the Year Ended 31 January 2024 continued Donallon8 and l•gacl08 Unrnstrlcted Total Fund8 Totsl Fund8 Fund8 2024 2023 Donatlon• and1gg4cl Donations Conference sponsor8hip Webinarsponsorship Corporate sponsorship 724 123.638 4,000 31,625 159,987 123,100 123.100 123.100 123.100 Of tha donations and *acies income in 2023 £159.987 related to unreslricted funds. Invo8tm•nt Incom• Unro8trlct•d Totsl Fund• Total Fund• Fund8 2024 2023 Interest on cash deposits 1,086 1,086 192 Of the inve8tment income in 2023, £192 related to unreJtricted fund3. Ch•rltsbl• •¢tlvltlo• Unrestrlcl•d Total Fund8 Total Fund• Funds 2024 2023 MOMr•hIp and ro8oar¢h Repre5enlation income Membership subscriptson8 1,017 7,920 8,937 1,017 7,920 8.937 8,220 8,220 Annual ¢onhrnn¢• Conference exhibitson only Delegate reglstrallon 8,743 22,358 31,099 8.743 22.356 31.099 10,945 17,855 28,800 40,036 40,036 37,020 Of the income from charitable activits'es in 2023 £37,020 related to unrestricted funds. Page 18
Lung Cancer Nursing UK known as LCNUK Notos to the Financlal Statements for the Year Ended 31 January 2024 , confy'nued Expondlture Member•hlp and r•8oarch Annual eonforonco Onllne Educatlon Total 2024 Total 2023 Dlr•¢t ¢o*t• Grants payable - indidual$ Webinar costs Membèrship administration costs TSG committ88 Costs Website costs DaSH Global Namgalor group expendilure Dèpendency tool RIG costs Annual workshop Parliamentary fly in costs Online leaming Venué costs Speaker costs and tokens Management fees Conference costs - materials Conferencè costs- other Irro¢ovorabl8 VAT 9,401 712 10,113 4,000 11,699 1,148 4,545 (11.8981 3,000 11.699 4,000 11,699 1,148 4,545 13.549 4,655 225 110 1,171 6,789 225 110 1,171 6,789 5.601 374 110 110 54,804 2,025 11,500 16,709 14,806 14771 139,277 54,804 2,025 11,500 18,709 14,806 56.832 2,385 11.500 13,926 18,099 1.172 130.894 14771 34,721 100,556 4,000 Support eo8t• Insurance Office management Commrttee costs R&presenlation costs AccountanGy and bookk8eping 246 1,915 601 464 247 1.914 247 1,914 600 463 740 5,743 1,801 1.391 703 5,743 2.063 1,696 216 415 5,553 1,697 217 416 5,555 1,697 217 416 5.554 5,090 650 1,247 16,662 4.935 650 1,073 16.051 Independent examinels fee Bank charges 40,274 1C6,111 9,554 155,939 146,945 Of the iotal expenditure in 2023 £146,945 relat8d to unrestricted funds. Page 19
Lung Cancer Nurslng UK known as LCNUK Notes to the Flnanclal Statements for the Year Ended 31 January 2024 . confynued Gr•ntm•klng Grants to IndlvSdual8 Membership and research Annual conference 9,401 712 10,113 Govornan¢• co•ts 2024 2023 Twstee meeting costs Accountanw fees Bookaeping fea8 Independent examlners fee 410 1.905 3,150 650 6,115 348 1,785 3,150 650 5.933 Tru•t•••' romun•r•llon •nd expon••• Committee meeting and travel expenses lotalling £332 12023.. £4791 Were paid to 1 {2023.' 2) of the trustses during the year. Page 20
Lung Cancer Nursing UK known as LCNUK Notes to the Flnanclal Statements forth• Year Ended 31 January 2024 . conlinu&d Taxatlon The registered chanty is exempl from tsxation on income and gains. 10 D•blor• 2024 2023 Trade debtors Other debtors Prepayments and arUe income 47.858 50.088 5.524 24,857 80,469 374 48,232 11 Cr•dltorn: Amounts falllng due wlthln one y•ar 2024 2023 Trade creditors Taxalion and social security Accruals and deferred income 118 6,919 50,700 57,735 2,914 9,504 12,418 Pag•21
Lung Cancer Nurslng UK known as LCNUK Notes to the Financlal Statements for the Year Ended 31 January 2024 . continued 12 Relat•d partle• Controlllng entity The charity is controlled by the truste8S. 13 An•lysls of fund• At1 F•bruary 2023 In¢omlng resourc?• R•ourco• At31 •xp•nd•d Janu•ry 2024 Genernl Fund8 Unrestncted incomè fund Prlor y•ar 320.292 164,222 {155,9391 328.575 At1 February 2022 In¢omlng r•8ourc R••ourco• At31 •xp•nd•d Jnuary 2023 G•noral Fund8 Unrestriced income fund 270,038 197,199 146.945 320,292 14 Not a•80ts by fund Unrnstrlctad Funds Totsl Fund# 2024 Total Fund• 2023 Current assets Crèditors.. Amounls falling due wthin one year Nel as$&ls 386,310 157,7351 328,575 386,310 157,735} 328.575 332,710 112,4181 320,292 PrIOrar Unrestrlcted funds Total fund• 2023 Total funds 2022 Current assets Creditors." Amounts falling due within one year Net assets 332,710 112,418) 320,292 332.710 112,4181 320,292 309,772 (39,734) 270,038 Pa98 22